| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/03/2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 95 | $0.00 | $0 | | 07/03/2023 |
| 05/31/2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 338 | $0.00 | $0 | | 05/31/2023 |
| 02/06/2023 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 214k | $6.50 | $1.4M | | 02/06/2023 |
| 05/11/2022 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 549 | $0.00 | $0 | | 05/11/2022 |
| 05/11/2022 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 292 | $0.00 | $0 | | 05/11/2022 |
| 05/11/2022 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Stock Options (Right to Buy) | 1.5k | $222.31 | $336.1k | | 05/11/2022 |
| 02/07/2022 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 62k | $15.04 | $932.5k | | 02/07/2022 |
| 01/11/2022 | Rallybio Corp | RLYB | Purchase | Common Stock | 4.5k | $10.65 | $47.9k | | 07/28/2021 |
| 01/10/2022 | Rallybio Corp | RLYB | Purchase | Common Stock | 5.5k | $10.10 | $55.6k | | 07/28/2021 |
| 01/03/2022 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 63 | $0.00 | $0 | | 01/03/2022 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (acquisition) | Common Stock | 272.6k | $0.00 | $0 | | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (acquisition) | Common Stock | 436.5k | $0.00 | $0 | See Footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Common Units | 2.3M | $0.00 | $0 | | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Common Units | 2.6M | $0.00 | $0 | See Footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Series A-1 Preferred Units | 150k | $0.00 | $0 | See Footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Series A-2 Preferred Units | 100k | $0.00 | $0 | See Footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Series B Preferred Units | 107.9k | $0.00 | $0 | See Footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 160k | $13.00 | $2.1M | | 07/28/2021 |
| 10/16/2020 | 5:01 Acquisition Corp. | | Other (acquisition) | Class B Common Stock | 30k | $0.00 | $0 | | 10/16/2020 |
| 05/11/2020 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 741 | $0.00 | $0 | | 05/11/2020 |
| 05/11/2020 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 457 | $0.00 | $0 | | 05/11/2020 |
| 05/11/2020 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Stock Options (Right to Buy) | 2.5k | $164.24 | $417k | | 05/11/2020 |
| 05/22/2019 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 1.9k | $0.00 | $0 | | 05/22/2019 |
| 05/22/2019 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 599 | $0.00 | $0 | | 05/22/2019 |
| 08/01/2017 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 2.2k | $0.00 | $0 | | 08/01/2017 |
| 08/01/2017 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | Grant | Common Stock | 607 | $0.00 | $0 | | 08/01/2017 |
| 03/01/2017 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 370 | $132.50 | $49k | | 02/27/2017 |
| 02/28/2017 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Option to Purchase Common Stock | 12.8k | $131.25 | $1.7M | | 02/27/2017 |
| 02/28/2017 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 625 | $131.70 | $82.3k | | 02/27/2017 |
| 02/28/2017 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 12.8k | $0.00 | $0 | | 02/27/2017 |
| 02/27/2017 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 860 | $131.20 | $112.8k | | 02/27/2017 |
| 05/14/2010 | PFIZER INC | PFE | Grant | Phantom Stock Units SSP | 236 | $16.20 | $3.8k | | 05/14/2010 |
| 03/31/2010 | PFIZER INC | PFE | Grant | Phantom Stock Units SSP | 111 | $17.15 | $1.9k | | 03/31/2010 |
| 03/15/2010 | PFIZER INC | PFE | Grant | Phantom Stock Units SSP | 2.7k | $17.26 | $46.9k | | 03/15/2010 |
| 02/25/2010 | PFIZER INC | PFE | Grant | Stock Appreciation Rights | 163.3k | $17.69 | $2.9M | | 02/25/2010 |
|